SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (232)2/25/2002 12:40:55 PM
From: nigel bates  Read Replies (1) | Respond to of 625
 
Nigel, do you have any insight into this?

Hi Wilder,

Not yet.

I'm still trying to find details of Chambre's departure from Celera - if you have access to the Baltimore Sun's online database (<g>), you could chase up this (expired) google link -
sunspot.net - nation/world
... came to a head after Celera' Chief Operating Officer Peter Chambre, formerly the
head of a United Kingdom drug-delivery company, stepped down in October after ...
www.sunspot.net/news/nationworld/bal-te.bz.celera23jan23.story?coll=bal-news-nation - 28k - Cached -


Could well answer you second question. <g>

nig